Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-01-01 @ 3:37 PM
Study NCT ID:
NCT00520403
Status:
COMPLETED
Last Update Posted:
2014-10-13
First Post:
2007-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-23
First Submit QC Date:
None
Study First Post Date:
2007-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-14
Results First Submit QC Date:
None
Results First Post Date:
2014-10-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-09
Last Update Post Date:
2014-10-13
Last Update Post Date Type:
ESTIMATED